Approvals/TGA/ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe

Approved

STANDARD

ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 59005014482a4f65
Product Name: ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe
Artg Id: 315497
Artg Name: ALPROLIX eftrenonacog alfa (rhu) 4000 IU powder for injection vial and diluent pre-filled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2020-01-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/c3731691b6fcf51d6d7d5c1967d62a00.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/cc04ea083f37f592353a2f635230182c.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

59005014482a4f65

Type

Standard